Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;267(5):1368-1376.
doi: 10.1007/s00415-019-09674-6. Epub 2020 Jan 24.

Microalbuminuria: a sentinel of neurocognitive impairment in HIV-infected individuals?

Affiliations

Microalbuminuria: a sentinel of neurocognitive impairment in HIV-infected individuals?

Antoine Moulignier et al. J Neurol. 2020 May.

Abstract

Background: According to population-based studies, microalbuminuria is associated with subsequent cognitive decline over a 4-6-year period, because of cerebral small-vessel disease (CSVD). This prospective cross-sectional study (NCT02852772) was designed to evaluate whether a history of microalbuminuria is associated with subsequent cognitive decline in combined antiretroviral therapy (cART)-treated persons living with human immunodeficiency virus (PLHIVs).

Methods: From our computerized medical database, we identified 30 PLHIVs (median age 52 years), immunovirologically controlled on cART, who had microalbuminuria in 2008 and had undergone, between 2013 and 2015, a comprehensive neuropsychological assessment (NPA) including seven domains (cases): information-processing speed, motor skills, executive functions, attention/working memory, learning/memory, reasoning and verbal fluency. Forty-nine PLHIVs matched for age (median age 48 years; p = 0.19), sex, and year of first HIV-seropositivity without microalbuminuria in 2008 were identified and underwent the same NPA between 2013 and 2015 (controls).

Results: Cases performed less well than controls for information-processing speed (p = 0.01) and motor skills (p = 0.02), but no differences were found for the other cognitive domains and global z-scores. A multivariable linear-regression model adjusted for confounding factors confirmed the microalbuminuria effect for the information-processing-speed z score.

Conclusion: cART-treated PLHIVs with a history of microalbuminuria subsequently had worse cognitive performances for the information-processing-speed domain, possibly because of CSVD. Our observations should be considered preliminary findings of a temporal link between microalbuminuria, CSVD, and subsequent cognitive impairment.

Keywords: Cerebral small-vessel disease (CSVD); HIV infection; Microalbuminuria; Neuropsychological assessment; Urine albumin/creatinine ratio (UACR).

PubMed Disclaimer

Conflict of interest statement

A. Moulignier: no disclosures. A.-C. Viret-Vilayphon: no disclosures. F.-X. Lescure: no disclosures. E. Plaisier: no disclosures. L. Salomon: no disclosures. C. Lamirel: honoraria from Novartis and Allergan for lectures; from Horus Pharma for consulting or an advisory role; from Allergan for travel, accommodations, and expenses. G. Pialoux: honoraria from Bristol-Myers Squibb, Viiv Healthcare, Gilead Sciences for lectures for consulting or an advisory role.

References

    1. Lee M, Ovbiagele B. Reno-cerebrovascular disease: linking the nephron and neuron. Expert Rev Neurother. 2011;11:241–249. doi: 10.1586/ern.10.204. - DOI - PubMed
    1. Mogi M, Horiuchi M. Clinical interaction between brain and kidney in small vessel disease. Cardiol Res Pract. 2011;2011:1–5. doi: 10.4061/2011/306189. - DOI - PMC - PubMed
    1. Toyoda K. Cerebral small vessel disease and chronic kidney disease. J Stroke. 2015;17:31–37. doi: 10.5853/jos.2015.17.1.31. - DOI - PMC - PubMed
    1. Chillon J-M, Massy ZA, Stengel B. Neurological complications in chronic kidney disease patients. Nephrol Dial Transplant. 2016;31:1606–1614. doi: 10.1093/ndt/gfv315. - DOI - PubMed
    1. Monk RD, Bennett DA. Reno-cerebrovascular disease? The incognito kidney in cognition and stroke. Neurology. 2006;67:196–198. doi: 10.1212/01.wnl.0000231530.04240.f8. - DOI - PubMed

Publication types

Substances